Bio-Connect

DCK antibody

GTX102800
GeneTex
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetDCK
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    DCK antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:1000-1:20000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1.41 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID1633
  • Target name
    DCK
  • Target description
    deoxycytidine kinase
  • Target synonyms
    deoxycytidine kinase, deoxyadenosine kinase, deoxyguanosine kinase, deoxynucleoside kinase
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP27707
  • Protein Name
    Deoxycytidine kinase
  • Scientific Description
    Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity. [provided by RefSeq]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Suksawat M, Klanrit P, Phetcharaburanin J, et al. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. PLoS One. 2019,14(9):e0222140. doi: 10.1371/journal.pone.0222140
    Read this paper
  • Sarr A, Bré J, Um IH, et al. Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031. Sci Rep. 2019,9(1):7643. doi: 10.1038/s41598-019-44089-3
    Read this paper
  • Kurata M, Rathe SK, Bailey NJ, et al. Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML. Sci Rep. 2016,6:36199. doi: 10.1038/srep36199
    Read this paper